ABT vs. COR: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ABT and COR, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
ABT dominates in value with a market cap of 231.49 billion USD, eclipsing COR’s 56.47 billion USD by roughly 4.10×.
With betas of 0.74 for ABT and 0.60 for COR, both show similar volatility profiles relative to the overall market.
| Symbol | ABT | COR |
|---|---|---|
| Company Name | Abbott Laboratories | Cencora, Inc. |
| Country | US | US |
| Sector | Healthcare | Healthcare |
| Industry | Medical - Devices | Medical - Distribution |
| CEO | Mr. Robert B. Ford | Dr. Robert P. Mauch Ph.D., PharmD |
| Price | 133.05 USD | 291.36 USD |
| Market Cap | 231.49 billion USD | 56.47 billion USD |
| Beta | 0.74 | 0.60 |
| Exchange | NYSE | NYSE |
| IPO Date | March 17, 1980 | April 4, 1995 |
| ADR | No | No |
Performance Comparison
This chart compares the performance of ABT and COR over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
For a detailed comparison of valuation metrics between ABT and COR, please refer to the table below.
| Symbol | ABT | COR |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 17.22 | 33.35 |
| Forward PEG Ratio (TTM) | 1.73 | 3.28 |
| Price-to-Sales Ratio (P/S, TTM) | 5.47 | 0.18 |
| Price-to-Book Ratio (P/B, TTM) | 2.48 | 55.75 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 34.77 | 15.80 |
| EV-to-EBITDA (TTM) | 22.97 | 16.96 |
| EV-to-Sales (TTM) | 5.63 | 0.20 |
| EV-to-Free Cash Flow (TTM) | 35.78 | 17.44 |
Dividend Comparison
ABT’s dividend yield of 1.71% is about 131% higher than COR’s 0.74%, underscoring its stronger focus on returning cash to shareholders.
| Symbol | ABT | COR |
|---|---|---|
| Dividend Yield (TTM) | 1.71% | 0.74% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of ABT and COR, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- COR’s current ratio of 0.87 indicates its assets may not cover near-term debts, whereas ABT at 1.78 maintains healthy liquidity.
- COR posts a quick ratio of 0.52, indicating limited coverage of short-term debts from its most liquid assets—while ABT at 1.27 enjoys stronger liquidity resilience.
- COR is highly leveraged (debt-to-equity ratio 7.76), elevating both potential gains and risks, compared to ABT at 0.14, which maintains a steadier capital structure.
| Symbol | ABT | COR |
|---|---|---|
| Current Ratio (TTM) | 1.78 | 0.87 |
| Quick Ratio (TTM) | 1.27 | 0.52 |
| Debt-to-Equity Ratio (TTM) | 0.14 | 7.76 |
| Debt-to-Assets Ratio (TTM) | 0.16 | 0.11 |
| Interest Coverage Ratio (TTM) | 15.39 | 9.41 |